India needs to aggressively ramp up coronavirus testing capacity as it can’t afford another lockdown or a wave of new active cases hitting hospitals, according to the head of one of the country’s largest drug makers.While some states are doing better than others, as a whole “we are way below the testing levels of other countries," Kiran Mazumdar-Shaw, the founder and chairman of Biocon Ltd., said at the Bloomberg India Economic Forum on Thursday. “We need to ramp up our testing -- the number of active cases are manageable at this point of time, but if the active cases start surging we simply don’t have the capacity."India, which in March imposed the largest nationwide lockdown globally in response to the pandemic, was taken by surprise by.